Market Cap 12.11B
Revenue (ttm) 638.50M
Net Income (ttm) -183.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -28.69%
Debt to Equity Ratio 2.16
Volume 548,394
Avg Vol 722,008
Day's Range N/A - N/A
Shares Out 51.46M
Stochastic %K 87%
Beta 0.59
Analysts Strong Sell
Price Target $265.10

Company Profile

Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults; Sunosi (solriamfetol), a dopamine and norepinephrine reuptak...

Industry: Biotechnology
Sector: Healthcare
Phone: 212 332 3241
Fax: 212 320 0245
Address:
One World Trade Center, 29th Floor, New York, United States
jeremytowe2000
jeremytowe2000 May. 15 at 8:39 PM
$AXSM added 1000 more at this price. 6000 shares are from 30s. May add 1000 more to keep 8000 shares and eventually see true 1000 per share.
0 · Reply
RiderInTheSky
RiderInTheSky May. 15 at 5:17 PM
$AXSM Nxt tues RBC Capital Markets invester conf maybe we get a bit of more good news. I hope someone finally asks the million $ question about any EU deal in the works
0 · Reply
pi22dv7
pi22dv7 May. 15 at 5:05 PM
0 · Reply
jlfromli
jlfromli May. 15 at 1:34 PM
$AXSM In 1k Swing!
1 · Reply
Mike826_1999
Mike826_1999 May. 15 at 12:49 PM
$AXSM Axsome: Auvelity for major depressive disorder Weekly TRx grew +1% w/w to 18,100, +33% Y/Y, and rolling 12-wk +31% Y/Y New prescriptions (NRx) / TRx were 57% for the week. (Morgan Stanley rounds to the nearest 100)
5 · Reply
jlfromli
jlfromli May. 14 at 6:38 PM
$AXSM Closed! $3.5k Let’s Go!
1 · Reply
StB55
StB55 May. 14 at 5:52 PM
$AXSM '' Clive Meanwell, chairman and partner at Population Health Partners, believes that the strong deal-making environment is poised to continue for at least the next few years. While dealmaking recently has focused on oncology and obesity, Meanwell sees this expanding into other areas, particularly central nervous system (CNS) assets.''
1 · Reply
noobzilla
noobzilla May. 14 at 1:56 PM
$AXSM I moved my 60% to $PCT on Monday. Finally another stock I feel worth keeping along with AXSM. Similar vibes to earlier days of AXSM where the product and data looks promising. Not drugs but new plastic recycling technology. They have an operating plant that is ramping up with many milestones and pending approvals ahead for more plants. Also has 40% short with 15 days to recover so huge short squeeze potential so not too late to join now. AXSM is a safer investment and still my favorite stock, but PCT worth checking out.
2 · Reply
cadbrad1
cadbrad1 May. 14 at 1:52 PM
$AXSM Buy these little dips. Going much higher!
0 · Reply
jlfromli
jlfromli May. 14 at 1:45 PM
$AXSM In 1k Swing!
1 · Reply
Latest News on AXSM
Axsome Therapeutics Recognizes Mental Health Month

May 7, 2026, 7:00 AM EDT - 8 days ago

Axsome Therapeutics Recognizes Mental Health Month


Axsome Therapeutics management to meet with Needham

2026-05-04T19:21:02.000Z - 11 days ago

Axsome Therapeutics management to meet with Needham


Axsome Therapeutics management to meet with Piper Sandler

2026-05-04T19:20:53.000Z - 11 days ago

Axsome Therapeutics management to meet with Piper Sandler


Axsome Therapeutics Earnings Call Transcript: Q1 2026

May 4, 2026, 8:00 AM EDT - 11 days ago

Axsome Therapeutics Earnings Call Transcript: Q1 2026


Axsome Therapeutics reports Q1 EPS ($1.26), consensus (86c)

2026-05-04T11:14:09.000Z - 11 days ago

Axsome Therapeutics reports Q1 EPS ($1.26), consensus (86c)


Axsome Therapeutics Transcript: FDA announcement

May 1, 2026, 8:00 AM EDT - 14 days ago

Axsome Therapeutics Transcript: FDA announcement


US FDA approves Axsome's drug for Alzheimer's-related agitation

Apr 30, 2026, 2:10 PM EDT - 15 days ago

US FDA approves Axsome's drug for Alzheimer's-related agitation


Axsome Therapeutics Earnings Call Transcript: Q4 2025

Feb 23, 2026, 8:00 AM EST - 2 months ago

Axsome Therapeutics Earnings Call Transcript: Q4 2025


Axsome Therapeutics Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:00 AM EST - 6 months ago

Axsome Therapeutics Earnings Call Transcript: Q3 2025


Axsome Therapeutics Earnings Call Transcript: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 10 months ago

Axsome Therapeutics Earnings Call Transcript: Q2 2025


Axsome Therapeutics Transcript: R&D Day 2025

Jul 21, 2025, 11:00 AM EDT - 10 months ago

Axsome Therapeutics Transcript: R&D Day 2025


Axsome Therapeutics Earnings Call Transcript: Q1 2025

May 5, 2025, 8:00 AM EDT - 1 year ago

Axsome Therapeutics Earnings Call Transcript: Q1 2025


Axsome Therapeutics Earnings Call Transcript: Q4 2024

Feb 18, 2025, 8:00 AM EST - 1 year ago

Axsome Therapeutics Earnings Call Transcript: Q4 2024


Axsome Therapeutics Transcript: FDA Announcement

Jan 31, 2025, 8:00 AM EST - 1 year ago

Axsome Therapeutics Transcript: FDA Announcement


US FDA approves Axsome Therapeutics' migraine drug

Jan 30, 2025, 3:55 PM EST - 1 year ago

US FDA approves Axsome Therapeutics' migraine drug


Axsome Therapeutics Transcript: Study Result

Dec 30, 2024, 8:00 AM EST - 1 year ago

Axsome Therapeutics Transcript: Study Result


Axsome Therapeutics Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Axsome Therapeutics Earnings Call Transcript: Q3 2024


Axsome Therapeutics Earnings Call Transcript: Q2 2024

Aug 5, 2024, 8:00 AM EDT - 1 year ago

Axsome Therapeutics Earnings Call Transcript: Q2 2024


Axsome Therapeutics Transcript: AGM 2024

Jun 7, 2024, 9:00 AM EDT - 2 years ago

Axsome Therapeutics Transcript: AGM 2024


Axsome Therapeutics Earnings Call Transcript: Q1 2024

May 6, 2024, 8:00 AM EDT - 2 years ago

Axsome Therapeutics Earnings Call Transcript: Q1 2024


jeremytowe2000
jeremytowe2000 May. 15 at 8:39 PM
$AXSM added 1000 more at this price. 6000 shares are from 30s. May add 1000 more to keep 8000 shares and eventually see true 1000 per share.
0 · Reply
RiderInTheSky
RiderInTheSky May. 15 at 5:17 PM
$AXSM Nxt tues RBC Capital Markets invester conf maybe we get a bit of more good news. I hope someone finally asks the million $ question about any EU deal in the works
0 · Reply
pi22dv7
pi22dv7 May. 15 at 5:05 PM
0 · Reply
jlfromli
jlfromli May. 15 at 1:34 PM
$AXSM In 1k Swing!
1 · Reply
Mike826_1999
Mike826_1999 May. 15 at 12:49 PM
$AXSM Axsome: Auvelity for major depressive disorder Weekly TRx grew +1% w/w to 18,100, +33% Y/Y, and rolling 12-wk +31% Y/Y New prescriptions (NRx) / TRx were 57% for the week. (Morgan Stanley rounds to the nearest 100)
5 · Reply
jlfromli
jlfromli May. 14 at 6:38 PM
$AXSM Closed! $3.5k Let’s Go!
1 · Reply
StB55
StB55 May. 14 at 5:52 PM
$AXSM '' Clive Meanwell, chairman and partner at Population Health Partners, believes that the strong deal-making environment is poised to continue for at least the next few years. While dealmaking recently has focused on oncology and obesity, Meanwell sees this expanding into other areas, particularly central nervous system (CNS) assets.''
1 · Reply
noobzilla
noobzilla May. 14 at 1:56 PM
$AXSM I moved my 60% to $PCT on Monday. Finally another stock I feel worth keeping along with AXSM. Similar vibes to earlier days of AXSM where the product and data looks promising. Not drugs but new plastic recycling technology. They have an operating plant that is ramping up with many milestones and pending approvals ahead for more plants. Also has 40% short with 15 days to recover so huge short squeeze potential so not too late to join now. AXSM is a safer investment and still my favorite stock, but PCT worth checking out.
2 · Reply
cadbrad1
cadbrad1 May. 14 at 1:52 PM
$AXSM Buy these little dips. Going much higher!
0 · Reply
jlfromli
jlfromli May. 14 at 1:45 PM
$AXSM In 1k Swing!
1 · Reply
jeremytowe2000
jeremytowe2000 May. 14 at 1:42 PM
$AXSM I guess they are good at flushing people who don’t want to see $1000 stock price in future
0 · Reply
Vakeshka
Vakeshka May. 14 at 12:15 PM
$AXSM another NGO, UCI MIND, issued an article on Auvelity for ADA. Unlike for MDD the company had to start from scratch and do a lot of leg work on its own, we now have multiple powerful external to the company entities that have already started to actively educate and build awareness to ultimately accelerate broad adoption across the target population. https://mind.uci.edu/fda-approves-a-second-drug-for-agitation-associated-with-alzheimers-disease-and-its-not-an-antipsychotic-medication/
0 · Reply
stocksetuplists
stocksetuplists May. 14 at 10:48 AM
Pharma mid-caps showing bull flag patterns: $CORT, $JAZZ, $EOLS, $AXSM Pharma is event-driven. Patterns can be overridden by trial readouts or FDA news. Pattern observation, not signals. Not investment advice.
0 · Reply
jeremytowe2000
jeremytowe2000 May. 13 at 7:31 PM
$AXSM I had this vision 3 years back for their pipeline. If anybody try to flush you out, this is the thing you need to look at it. Print this and keep it in your office/bedroom/toilet or wherever you can see everyday.
1 · Reply
cadbrad1
cadbrad1 May. 13 at 7:15 PM
$AXSM Very Bullish action!!!!
0 · Reply
RiderInTheSky
RiderInTheSky May. 13 at 7:10 PM
$AXSM did our MC go up 2 bin on yahoo today. I could’ve swore it was around 10 now at 12 ?
1 · Reply
WAJeff
WAJeff May. 13 at 6:50 PM
$AXSM $JAZZ $MIRM $RVMD My favorite bios. What are yours? No sub-$10 ideas as a request
9 · Reply
HillbillyWilly
HillbillyWilly May. 13 at 6:33 PM
$AXSM Feels like something different going on.
0 · Reply
Biotechinvestor101
Biotechinvestor101 May. 13 at 6:23 PM
$AXSM new ATH
1 · Reply
jlfromli
jlfromli May. 13 at 6:07 PM
$AXSM Wait until The CNBC guys Wake up. 😂 Nah, they are Stuck with their 10 rotating symbols.
2 · Reply
Georgejj
Georgejj May. 13 at 5:05 PM
$AXSM https://finance.yahoo.com/news/axsome-therapeutics-bets-auvelity-expansion-220812577.html
0 · Reply
chuckL4
chuckL4 May. 13 at 4:41 PM
$AXSM Wonder how much they can get for the Ex US rights to Auvelity. When management mentions an $8 billion plus opportunity for the drug I believe they are not including what they will get for licensing the rights outside the US. They now should have the incentive to sell these rights now that Alzheimer Agitation has been approved
3 · Reply